If it happens I think it would be more targeted and with a 50% stake into specific treatments, rather than the company as a whole.
At the end of the day so many thinks could happen. The SP could fall and stay low for some time or permanently. It also could fall then rise slowly over the next few months. Another possibility if it is a partnership with Novartis or other large pharmaceutical company is that the SP could surge. If another company fast tracks trials, takes over distribution and other aspects, pushes for FDA approval, then it could fly. Dilution doesn't matter if they get massive funding and backing. But any of the options are possible. GLTAH.
If it happens I think it would be more targeted and with a 50%...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.005(0.45%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.15 | $1.11 | $5.667M | 5.064M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 94111 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 70945 | 3 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.12 |
Change
-0.005 ( 1.73 %) |
||||
| Open | High | Low | Volume | ||
| $1.11 | $1.15 | $1.11 | 871975 | ||
| Last updated 15.59pm 03/06/2024 ? | |||||
| MSB (ASX) Chart |